Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma

Published 2017 View Full Article

  1. Home
  2. Publications
  3. Publication Search
  4. Publication Details
Title
Hypomethylation of BORIS is a promising prognostic biomarker in hepatocellular carcinoma
Authors
Keywords
BORIS, DNA demethylation, MSP, HCC, Prognosis
Journal
GENE
Volume 629, Issue -, Pages 29-34
Publisher
Elsevier BV
Online
2017-07-29
DOI
10.1016/j.gene.2017.07.077

Ask authors/readers for more resources

Protocol

Community support

Reagent

Community support

Reprint

Contact the author

Find Funding. Review Successful Grants.

Explore over 25,000 new funding opportunities and over 6,000,000 successful grants.

Explore

Become a Peeref-certified reviewer

The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.

Get Started
Webinars Posters Questions Hubs Funding Journals Articles Connect Collections Reviewers About Us FAQs Mobile App Privacy Policy Terms of Use
© Peeref 2019-2024. All rights reserved.